Epstein-Barr virus genotypes and strains in central nervous system demyelinating disease and Epstein-Barr virus-related illnesses in Australia

Intervirology

Volumn 55, Issue 5, 2012, Pages 372-379

  Lay, Meav Lang J ^a,d   Lucas, Robyn M ^b   Toi, Cheryl ^a   Ratnamohan, Mala ^a   Ponsonby, Anne Louise ^c   Dwyer, Dominic E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b The Australian National University   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

Author keywords

Australia; Central nervous system demyelination; Epstein Barr virus; Epstein Barr virus related diseases; Genotype; Multiple sclerosis; Sequencing

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 2; VIRUS DNA;

ARTICLE; AUSTRALIA; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATING DISEASE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; VIRUS STRAIN;

AUSTRALIA; CENTRAL NERVOUS SYSTEM; CLUSTER ANALYSIS; DEMYELINATING DISEASES; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; GENOTYPE; HERPESVIRUS 4, HUMAN; HUMANS; PHYLOGENY; SEQUENCE ANALYSIS, DNA;

HUMAN HERPESVIRUS 4;

EID: 84861456437     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000334693     Document Type: Article

References (55)

1. Faulkner GC, Krajewski AS, Crawford DH: The ins and outs of EBV infection. Trends Microbiol 2000; 8: 185-189.
2. Kullberg-Lindh C, Ascher H, Saalman R, Olausson M, Lindh M: Epstein-Barr viremia levels after pediatric liver transplantation as measured by real-time polymerase chain reaction. Pediatr Transplant 2006; 10: 83-89.
3. Broccolo F, Bossolasco S, Careddu AM, Tambussi G, Lazzarin A, Cinque P: Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus- infected patients: frequency and clinical significance. Clin Diagn Lab Immunol 2002; 9: 1222-1228.
4. Young LS, Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4: 757-768.
5. Christensen T: The role of EBV in MS pathogenesis. Int MS J 2006; 13: 52-57.
6. DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A: Epstein- Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 2006; 63: 839-844.
7. Chang CM, Yu KJ, Mbulaiteye SM, Hildesheim A, Bhatia K: The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res 2009; 143: 209-221.
8. Rickinson AB, Young LS, Rowe M: Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virustransformed B cells. J Virol 1987; 61: 1310-1317.
9. Robaina TF, Valladares CP, Tavares DS, Napolitano WC, Silva LE, Dias EP, Leite JP: Polymerase chain reaction genotyping of Epstein-Barr virus in scraping samples of the tongue lateral border in HIV-1 seropositive patients. Mem Inst Oswaldo Cruz 2008; 103: 326-331.
10. Lucchesi W, Brady G, Dittrich-Breiholz O, Kracht M, Russ R, Farrell PJ: Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2. J Virol 2008; 82: 7456-7466.
11. Gutierrez MI, Kingma DW, Sorbara L, Tran M, Raffeld M, Jaffe ES, Magrath I, Bhatia K: Association of EBV strains, defined by multiple loci analyses, in non-Hodgkin lymphomas and reactive tissues from HIV positive and HIV negative patients. Leuk Lymphoma 2000; 37: 425-429.
12. Higa M, Kinjo T, Kamiyama K, Iwamasa T, Hamada T, Iyama K: Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan. J Clin Pathol 2002; 55: 414-423.
13. Brennan RM, Burrows JM, Bell MJ, Bromham L, Csurhes PA, Lenarczyk A, Sverndal J, Klintenstedt J, Pender MP, Burrows SR: Strains of Epstein-Barr virus infecting multiple sclerosis patients. Mult Scler 2010; 16: 643-651.
14. Weinreb M, Day PJ, Niggli F, Powell JE, Raafat F, Hesseling PB, Schneider JW, Hartley PS, Tzortzatou-Stathopoulou F, Khalek ER, Mangoud A, El-Safy UR, Madanat F, Al Sheyyab M, Mpofu C, Revesz T, Rafii R, Tiedemann K, Waters KD, Barrantes JC, Nyongo A, Riyat MS, Mann JR: The role of Epstein- Barr virus in Hodgkin's disease from different geographical areas. Arch Dis Child 1996; 74: 27-31.
15. Sculley TB, Cross SM, Borrow P, Cooper DA: Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virus. J Infect Dis 1988; 158: 186-192.
16. Apolloni A, Sculley TB: Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes. Virology 1994; 202: 978-981.
17. Lucas RM, Ponsonby AL, Dear K, Valery P, Pender MP, Burrows JM, Burrows SR, Chapman C, Coulthard A, Dwyer DE, Dwyer T, Kilpatrick T, Lay ML, McMichael AJ, Taylor BV, van der Mei IA, Williams D: Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Neurology 2011;77:371-379.
18. Lay ML, Lucas RM, Ratnamohan M, Taylor J, Ponsonby AL, Dwyer DE: Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye. Virol J 2010; 7: 252.
19. Yang Y, Hebron HR, Hang J: A method for preparing DNA sequencing templates using a DNA-binding microplate. J Biomol Tech 2009; 20: 165-171.
20. Hall TA: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 1999; 41: 95-98.
21. Altschul S, Madden T, Schäffer A, Zhang J, Zhang Z, Miller W, Lipman D: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25: 3389-3402.
22. Saitou N, Nei M: The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4: 406-425.
23. Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596-1599.
24. Kimura M: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980; 16: 111-120.
25. Felsenstein J: Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985; 39: 783-791.
26. Nei M, Kumar S: Molecular Evolution and Phylogenetics. New York, Oxford University Press, 2000.
27. Zimber U, Adldinger HK, Lenoir GM, et al: Geographical prevalence of two types of Epstein- Barr virus. Virology 1986; 154: 56-66.
28. Munch M, Hvas J, Christensen T, Moller- Larsen A, Haahr S: A single subtype of Epstein- Barr virus in members of multiple sclerosis clusters. Acta Neurol Scand 1998; 98: 395-399.
29. Ibrahim HA, Menasce LP, Pomplun S, Burke M, Bower M, Naresh KN: Epstein-Barr virus (EBV) genotypes among human immunodeficiency virus (HIV)-related B-cell lymphomas and B-cell post-transplant lymphoproliferative disorders (B-PTLD)-late-onset lymphomas, especially in the HIV setting, are associated with type-B-EBV. Eur J Haematol 2010; 85: 227-230.
30. Jin Y, Xie Z, Lu G, Yang S, Shen K: Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBVassociated diseases in Chinese children. Virol J 2010; 7: 92.
31. Mendes TM, Oliveira LC, Yamamoto L, Del Negro GM, Okay TS: Epstein-Barr virus nuclear antigen-2 detection and typing in immunocompromised children correlated with lymphoproliferative disorder biopsy findings. Braz J Infect Dis 2008; 12: 186-191.
32. Correa RM, Fellner MD, Durand K, Redini L, Alonio V, Yampolsky C, Colobraro A, Sevlever G, Teyssie A, Benetucci J, Picconi MA: Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients. J Med Virol 2007; 79: 401-407.
33. Yang TT, Wang Y, Liu X, Li X, Pang ZC, Luo B: Genotyping of Epstein Barr virus in Epstein Barr virus associated gastric carcinoma. Bing Du Xue Bao 2009; 25: 29-34.
34. Zeng MS, Li DJ, Liu QL, Song LB, Li MZ, Zhang RH, Yu XJ, Wang HM, Ernberg I, Zeng YX: Genomic sequence analysis of Epstein Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J Virol 2005; 79: 15323-15330.
35. Cui Y, Wang Y, Liu X, Chao Y, Xing X, Zhao C, Liu C, Luo B: Genotypic analysis of Epstein- Barr virus isolates associated with nasopharyngeal carcinoma in Northern China. Intervirology 2010; 54: 131-138.
36. Ascherio A, Munger KL: Environmental risk factors for multiple sclerosis. I. The role of infection. Ann Neurol 2007; 61: 288-299.
37. Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I, Dilitz E, Deisenhammer F, Reindl M: Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003; 349: 139-145.
38. Lindsey JW, Patel S, Zou J: Epstein-Barr virus genotypes in multiple sclerosis. Acta Neurol Scand 2008; 117: 141-144.
39. Simon KC, Yang X, Munger KL, Ascherio A: EBNA1 and LMP1 variants in multiple sclerosis cases and controls. Acta Neurol Scand 2011; 124: 53-58.
40. Sculley TB, Apolloni A, Hurren L, Moss DJ, Cooper DA: Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis 1990; 162: 643-648.
41. Buisson M, Morand P, Genoulaz O, Bourgeat MJ, Micoud M, Seigneurin JM: Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. J Gen Virol 1994; 75: 431-437.
42. Sixbey JW, Shirley P, Chesney PJ, Buntin DM, Resnick L: Detection of a second widespread strain of Epstein-Barr virus. Lancet 1989;2:761-765.
43. Kyaw MT, Hurren L, Evans L, Moss DJ, Cooper DA, Benson E, Esmore D, Sculley TB: Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Res Hum Retrovir 1992; 8: 1869-1874.
44. Frank D, Cesarman E, Liu YF, Michler RE, Knowles DM: Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 1995; 85: 1396-1403.
45. Puchhammer-Stockl E, Gorzer I: Cytomegalovirus and Epstein-Barr virus subtypes - the search for clinical significance. J Clin Virol 2006; 36: 239-248.
46. Plaza G, Santon A, Bellas C: Coinfection by multiple strains of Epstein-Barr virus in infectious mononucleosis in immunocompetent patients. Acta Otolaryngol 2003; 123: 543-546.
47. Sitki-Green D, Covington M, Raab-Traub N: Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J Virol 2003; 77: 1840-1847.
48. Skare J, Edson C, Farley J, Strominger JL: The B95-8 isolate of Epstein-Barr virus arose from an isolate with a standard genome. J Virol 1982; 44: 1088-1091.
49. Young LS, Yao QY, Rooney CM, Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB: New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J Gen Virol 1987; 68: 2853-2862.
50. Abdel-Hamid M, Chen JJ, Constantine N, Massoud M, Raab-Traub N: EBV strain variation: geographical distribution and relation to disease state. Virology 1992; 190: 168-175.
51. Elliott SL, Suhrbier A, Miles JJ, Lawrence G, Pye SJ, Le TT, Rosenstengel A, Nguyen T, Allworth A, Burrows SR, Cox J, Pye D, Moss DJ, Bharadwaj M: Phase I trial of a CD8+ Tcell peptide epitope-based vaccine for infectious mononucleosis. J Virol 2008; 82: 1448-1457.
52. Norberg P: Divergence and genotyping of human alpha-herpesviruses: an overview. Infect Genet Evol 2010; 10: 14-25.
53. McGeoch DJ, Gatherer D: Lineage structures in the genome sequences of three Epstein- Barr virus strains. Virology 2007; 359: 1-5.
54. Lin JC, Lin SC, De BK, Chan WP, Evatt BL, Chan WC: Precision of genotyping of Epstein- Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA- 3C, and EBER): predominance of type A virus associated with Hodgkin's disease. Blood 1993; 81: 3372-3381.
55. Wesche PL, Gaffney DJ, Keightley PD: DNA sequence error rates in Genbank records estimated using the mouse genome as a reference. DNA Seq 2004; 15: 362-364.